User profiles for R. Gosens
Reinoud GosensUniversity of Groningen Verified email at rug.nl Cited by 11130 |
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma
…, WT Gerthoffer, SH Gilbert, R Gosens… - European …, 2007 - Eur Respiratory Soc
Excessive airway obstruction is the cause of symptoms and abnormal lung function in asthma.
As airway smooth muscle (ASM) is the effecter controlling airway calibre, it is suspected …
As airway smooth muscle (ASM) is the effecter controlling airway calibre, it is suspected …
[HTML][HTML] Muscarinic receptor signaling in the pathophysiology of asthma and COPD
Anticholinergics are widely used for the treatment of COPD, and to a lesser extent for asthma.
Primarily used as bronchodilators, they reverse the action of vagally derived acetylcholine …
Primarily used as bronchodilators, they reverse the action of vagally derived acetylcholine …
Airway structural components drive airway smooth muscle remodeling in asthma
Chronic asthma is an inflammatory airways disease characterized by pathological changes
in the airway smooth muscle (ASM) bundle that contribute to airway obstruction and …
in the airway smooth muscle (ASM) bundle that contribute to airway obstruction and …
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
IST Bos, R Gosens, AB Zuidhof… - European …, 2007 - Eur Respiratory Soc
Chronic inflammation in asthma and chronic obstructive pulmonary disease drives
pathological structural remodelling of the airways. Using tiotropium bromide, acetylcholine was …
pathological structural remodelling of the airways. Using tiotropium bromide, acetylcholine was …
Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling
R Gosens, IST Bos, J Zaagsma… - American journal of …, 2005 - atsjournals.org
Rationale: Recent findings have demonstrated that muscarinic M 3 receptor stimulation
enhances airway smooth muscle proliferation to peptide growth factors in vitro. Because both …
enhances airway smooth muscle proliferation to peptide growth factors in vitro. Because both …
[HTML][HTML] Activation of WNT / β-Catenin Signaling in Pulmonary Fibroblasts by TGF-β1 Is Increased in Chronic Obstructive Pulmonary Disease
Background Chronic obstructive pulmonary disease (COPD) is characterized by abnormal
extracellular matrix (ECM) turnover. Recently, activation of the WNT/β-catenin pathway has …
extracellular matrix (ECM) turnover. Recently, activation of the WNT/β-catenin pathway has …
Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle
R Gosens, GL Stelmack, G Dueck… - … of Physiology-Lung …, 2006 - journals.physiology.org
… R. Gosens received support from the National Training Program in Allergy and Asthma and
is currently the recipient of a Marie Curie Outgoing International Fellowship (no. 008823). AJ …
is currently the recipient of a Marie Curie Outgoing International Fellowship (no. 008823). AJ …
Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019
…, PA de Jong, R Gosens… - Clinical Infectious …, 2021 - academic.oup.com
Background Respiratory failure and thromboembolism are frequent in severe acute respiratory
syndrome coronavirus 2–infected patients. Vitamin K activates both hepatic coagulation …
syndrome coronavirus 2–infected patients. Vitamin K activates both hepatic coagulation …
The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets
HA Baarsma, M Königshoff, R Gosens - Pharmacology & therapeutics, 2013 - Elsevier
Wingless/integrase-1 (WNT) signaling is a key pathway regulating various aspects of
embryonic development; however it also underlies several pathological conditions in man, …
embryonic development; however it also underlies several pathological conditions in man, …
The genetics of asthma and the promise of genomics-guided drug target discovery
Asthma is an inflammatory airway disease that is estimated to affect 339 million people
globally. The symptoms of about 5–10% of patients with asthma are not adequately controlled …
globally. The symptoms of about 5–10% of patients with asthma are not adequately controlled …